Active Surveillance for Low Risk Nonmuscle Invasive Bladder Cancer: A Confirmatory and Resource Consumption Study from the BIAS Project-Reference-Cited by-同舟云学术

Active Surveillance for Low Risk Nonmuscle Invasive Bladder Cancer: A Confirmatory and Resource Consumption Study from the BIAS Project

Published:2018-02 Issue:2 Volume:199 Page:401-406
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Hurle Rodolfo¹,Lazzeri Massimo¹,Vanni Elena²³,Lughezzani Giovanni¹,Buffi NicolòMaria¹,Casale Paolo¹,Saita Alberto¹,Morenghi Emanuela⁴³,Forni Giovanni¹,Cardone Pasquale¹,Lista Giuliana¹,Colombo Piergiuseppe⁵,Peschechera Roberto¹,Pasini Luisa¹,Zandegiacomo Silvia¹,Benetti Alessio¹,Maffei Davide¹,Vavassori Ivano⁶,Guazzoni Giorgio¹²³

Affiliation:

1. Department of Urology, Istituto Clinico Humanitas Istituto di Ricovero e Cura a Carattere Scientifico-Clinical and Research Hospital, Milan, Italy

2. Business Operations Office, Humanitas Clinical and Research Center, Milan, Italy

3. Department of Biomedical Science, Humanitas University, Milan, Italy

4. Department of Biostatistics, Istituto Clinico Humanitas Istituto di Ricovero e Cura a Carattere Scientifico-Clinical and Research Hospital, Milan, Italy

5. Department of Pathology, Istituto Clinico Humanitas Istituto di Ricovero e Cura a Carattere Scientifico-Clinical and Research Hospital, Milan, Italy

6. Department of Urology, Ospedale di Treviglio, Bergamo, Italy

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference19 articles.

1. Primary superficial bladder cancer risk groups according to progression, mortality and recurrence;Millan-Rodriguez;J Urol,2000

2. Long-term cancer-specific outcomes of TaG1 urothelial carcinoma of the bladder;Rieken;Eur Urol,2014

3. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials;Sylvester;Eur Urol,2006

4. Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: a combined analysis of seven EORTC studies;Brausi;Eur Urol,2002

5. Expectant management of small, recurrent, noninvasive papillary bladder tumors;Soloway;J Urol,2003

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cáncer de vejiga: diagnóstico y principios terapéuticos;EMC - Urología;2024-08

2. Deintensification of Treatment for Low-grade Bladder Tumors: A Collaborative Review by the International Bladder Cancer Group (IBCG);European Urology Oncology;2024-08

3. Advanced optical imaging techniques for bladder cancer detection and diagnosis: a systematic review;BJU International;2024-07-17

4. Point de vue de l’urologue : apport de la cytologie urinaire dans le diagnostic et la prise en charge des tumeurs urothéliales;Annales de Pathologie;2024-05

5. Long‐term outcomes and cost savings of office fulguration of papillary Ta low‐grade bladder cancer;BJU International;2024-01-05